stockrow
Friday 6 November 2026
Export DBD’s income statement to Excel — free account
Diebold Nixdorf, Incorporated
DBD Technology Software Application
Diebold Nixdorf, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 1.46% from fiscal 2024.
- Revenue
- +5.19%
- EPS
- −81.4%
- Free cash flow
- −346.1%
- Total debt
- +1.64%
Quarter to September 2026, against a year earlier
58.30
0.32
+0.55%
Follow DBD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
25.81 | 25.23 | 27.34 | 27.95 |
P/S ratio |
0.66 | 0.69 | 0.76 | 0.53 | |
P/FCF ratio |
10.45 | 10.44 | 13.80 | 16.22 | |
P/Operating CF |
11.49 | 83.53 | (215.05) | (43.53) | |
P/B ratio |
2.26 | 2.58 | 3.00 | 2.19 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.79 | 0.83 | 0.93 | 0.72 | |
EV/EBITDA |
8.04 | 8.53 | 9.50 | 8.26 | |
EV/Operating CF |
10.04 | 10.15 | 13.13 | 15.02 | |
EV/FCF |
12.64 | 12.67 | 16.91 | 22.23 | |
Quick Ratio |
0.79 | 0.69 | 0.69 | 0.66 | |
Current Ratio |
1.30 | 1.28 | 1.27 | 1.27 | |
Net Debt/EBITDA |
4.55 | 8.60 | 7.36 | 10.60 | |
Debt/Assets |
24.35% | 24.53% | 25.23% | 25.91% | |
Debt/Equity |
0.85 | 0.92 | 0.97 | 1.01 | |
Asset Turnover |
1.03 | 1.03 | 1.04 | 1.06 | |
Operating CF/Net income |
4.39 | 6.34 | (0.88) | (7.18) | |
Capex/Depreciation |
(0.67) | (0.33) | (0.47) | (0.39) | |
Interest Coverage |
4.00 | 1.40 | 2.38 | 1.45 | |
Research and Development Expense of Revenue |
1.93% | 2.48% | 2.20% | 1.99% | |
Selling, General and Administrative Expense of Revenue |
15.90% | 17.63% | 17.44% | 17.32% | |
Intangible Assets out of Total Assets |
0.37 | 0.36 | 0.37 | 0.37 | |
Share Based Compensation of Revenue |
0.25% | 0.36% | 0.45% | 0.43% | |
Graham Net Nets |
(0.39) | (0.38) | (0.36) | (0.52) | |
Graham Number |
42.15 | 44.35 | 44.57 | 37.16 | |
Earnings Yield |
3.87% | 3.96% | 3.66% | 3.58% | |
Free Cash Flow Yield |
9.57% | 9.58% | 7.25% | 6.17% | |
Revenue per Share |
30.01 | 25.41 | 27.06 | 29.50 | |
Operating CF per Share |
5.91 | 0.90 | (0.40) | (1.41) | |
Capex per Share |
(0.59) | (0.31) | (0.44) | (0.38) | |
Free Cash Flow per Share |
5.32 | 0.59 | (0.84) | (1.79) | |
Cash per Share |
11.32 | 10.64 | 8.21 | 5.49 | |
Shareholders Equity per Share |
30.02 | 29.24 | 28.39 | 28.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.02 | 29.24 | 28.39 | 28.01 | |
Free Cash Flow |
195.70 | 20.70 | (28.90) | (60.30) | |
Working Capital |
415.30 | 396.10 | 361.00 | 352.00 | |
Capital Expenditures |
(21.80) | (11.00) | (15.30) | (12.90) | |
Net Current Asset Value |
(962.80) | (1,003.60) | (1,048.30) | (1,064.10) | |
EV/EBIT |
12.48 | 13.11 | 14.56 | 13.38 | |
Capex to Sales |
0.02 | 0.01 | 0.02 | 0.01 | |
Price to Operating Income |
10.32 | 10.80 | 11.87 | 9.76 | |
| Other line items | |||||
Average Receivables |
628.65 | 599.80 | 625.80 | 630.10 | |
Average Payables |
445.65 | 466.05 | 468.75 | 477.35 | |
Average Inventory |
524.55 | 553.05 | 584.95 | 580.70 | |
Average Assets |
3,698.95 | 3,727.75 | 3,738.25 | 3,693.60 | |
Average Common Equity |
1,021.50 | 1,008.60 | 1,040.75 | 1,028.25 |
Columns are period end dates · fundamentals updated 2 Nov 2026